A Review of Escitalopram and Citalopram in Child and Adolescent Depression

Journal of the Canadian Academy of Child and Adolescent Psychiatry

Volumn 20, Issue 4, 2011, Pages 315-324

  Carandang, Carlo ^a,b   Jabbal, Rekha ^c   MacBride, Angela ^c   Elbe, Dean ^d  

^a IWK HEALTH CENTRE   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c ALBERTA HEALTH SERVICES   (Canada)

^d BC CHILDREN S HOSPITAL   (Canada)

Author keywords

Adolescent; Child; Citalopram; Depression; Escitalopram

Indexed keywords

CITALOPRAM; ESCITALOPRAM; PLACEBO;

ABDOMINAL PAIN; ACCIDENTAL INJURY; ADOLESCENT; ADULT; AGITATION; APPETITE; AREA UNDER THE CURVE; BACKACHE; CHILD; CONTROLLED STUDY; DEPRESSION; DIAPHORESIS; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG BIOAVAILABILITY; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MARKETING; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERSOMNIA; HYPOMANIA; INSOMNIA; LAW SUIT; LIBIDO; MAJOR CLINICAL STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; NAUSEA; PNEUMONIA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHINITIS; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; SUICIDAL IDEATION; SUICIDE; SWEATING; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT DURATION; TREATMENT RESPONSE; TREMOR; VOMITING;

EID: 80955151269     PISSN: 17198429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Baumgartner, J. L., Emslie, G. J., & Crismon, M. L. (2002). Citalopram in children and adolescents with depression or anxiety. The Annals of Pharmacotherapy, 36(11), 1692-1697.
2. Bostic, J. Q., Prince, J., Brown, K., & Place, S. (2001). A retrospective study of citalopram in adolescents with depression. Journal of Child and Adolescent Psychopharmacology, 11(2), 159-166.
3. Centre for Evidence Based Medicine. (2001). Levels of evidence. Retrieved July 16, 2008, from http://www.cebm.net/index. aspx?o=1025
4. Eli Lilly & Co. (2011). Prozac prescribing information (US). Retrieved May 27, 2011, from http://pi.lilly.com/prozac.pdf
5. Emslie, G. J., Ventura, D., Korotzer, A., & Tourkodimitris, S. (2009). Escitalopram in the treatment of adolescent depression: A randomized placebo-controlled multisite trial. Journal of the American Academy of Child and Adolescent Psychiatry, 48(7), 721-729.
6. Findling, R., Bose, A., Aquino, D., Korotzer, A., & Tourkodimitris, S. (2008). Six-month double-blind escitalopram treatment of depressed adolescents. Poster Presentation at American Academy of Child & Adolescent Psychiatry Annual Meeting, Chicago.
7. Forest Laboratories, Inc. (2010). Forest laboratories, Inc. finalizes previously disclosed settlement of U.S. government investigations and related civil qui tam litigation relating to past sales and marketing activities. Retrieved May 27, 2011, from http://www.frx.com/news/ PressRelease.aspx?ID=1471624
8. Freedman, R., & Roy, M. D. (2009). Editor's note. American Journal of Psychiatry, 166(8), 942-943.
9. Hazell, P., O'Connell, D., Heathcote, D., & Henry, D. (2002). Tricyclic drugs for depression in children and adolescents. Cochrane Database of Systematic Reviews (Online), (2), CD002317.
10. Hyttel, J., Bogeso, K. P., Perregaard, J., & Sanchez, C. (1992). The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer. Journal of Neural Transmission General Section, 88(2), 157-160.
11. TM, Hudson, Ohio: Lexi-Comp, Inc.; 2011; May 27, 2011.
12. Lundbeck Canada Inc. (2011). Cipralex product monograph. Retrieved 05/27, 2011, from http://webprod.hc-sc.gc.ca/dpd-bdpp/item-iteme. do?pm-mp=00013046
13. Miriyala, K., & Coffey, B. (2008). Renal failure in a depressed adolescent on escitalopram. Journal of Child and Adolescent Psychopharmacology, 18(4), 405-408.
14. Periclou, A., Rao, N., Sherman, T., Ventura, D., & Abramowitz, W. (2003). Single-dose pharmacokinetic study of escitalopram in adolescents and adults [Abstract]. Pharmacotherapy, 10, 1361-1362.
15. Rao, N. (2007). The clinical pharmacokinetics of escitalopram. Clinical Pharmacokinetics, 46(4), 281-290.
16. Reis, M., Olsson, G., Carlsson, B., Lundmark, J., Dahl, M. L., Walinder, J.,... Bengtsson F. (2002). Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting. Journal of Clinical Psychopharmacology, 22(4), 406-413.
17. Schirman, S., Kronenberg, S., Apter, A., Brent, D., Melhem, N., Pick, N.,... Gothelf, D. (2010). Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: An open-label study. Journal of Neural Transmission (Vienna, Austria: 1996), 117(1), 139-145.
18. Shirazi, E., & Alaghband-Rad, J. (2005). An open trial of citalopram in children and adolescents with depression. Journal of Child and Adolescent Psychopharmacology, 15(2), 233-239.
19. von Knorring, A. L., Olsson, G. I., Thomsen, P. H., Lemming, O. M., & Hulten, A. (2006). A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder. Journal of Clinical Psychopharmacology, 26(3), 311-315.
20. Wagner, K. D., Jonas, J., Findling, R. L., Ventura, D., & Saikali, K. (2006). A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. Journal of the American Academy of Child and Adolescent Psychiatry, 45(3), 280-288.
21. Wagner, K. D., Robb, A. S., Findling, R. L., Jin, J., Gutierrez, M. M., & Heydorn, W. E. (2004). A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. The American Journal of Psychiatry, 161(6), 1079-1083.
22. Yan, J. (2009). FDA approves antidepressant for use in adolescents. Psychiatric News, 44(9), 2.